RNXT 10-20x multi-bagger. Could be even more if they dont get acquired after phase 3 positive results. Could expand into other cancers/tumors and global markets pushing the valuation easily into the $15-20billion market cap.RenovoRx, Inc. stock forum
RNXT 10-20x multi-bagger. Could be even more if they dont get acquired after phase 3 positive results. Could expand into other cancers/tumors and global markets pushing the valuation easily into the $15-20billion market cap.